Compile Data Set for Download or QSAR
maximum 50k data
Found 40 Enz. Inhib. hit(s) with all data for entry = 50044662
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  370nMAssay Description:Inhibition of DRAK2 (unknown origin) using 1 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  510nMAssay Description:Inhibition of DRAK2 (unknown origin) using 5 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  530nMAssay Description:Inhibition of DRAK2 (unknown origin) using 10 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  560nMAssay Description:Inhibition of DRAK1 (unknown origin) using 1 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  630nMAssay Description:Inhibition of DRAK1 (unknown origin) using 5 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  650nMAssay Description:Inhibition of DRAK2 (unknown origin) using 25 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  710nMAssay Description:Inhibition of DRAK1 (unknown origin) using 10 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  720nMAssay Description:Inhibition of DRAK2 (unknown origin) using 50 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  860nMAssay Description:Inhibition of DRAK2 (unknown origin) using 33P-ATP after 30 mins by Trilux scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  940nMAssay Description:Inhibition of DRAK1 (unknown origin) using 25 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  990nMAssay Description:Inhibition of DRAK2 (unknown origin) using 100 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  1.33E+3nMAssay Description:Inhibition of DRAK1 (unknown origin) using 50 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  1.47E+3nMAssay Description:Inhibition of DRAK2 (unknown origin) using 250 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024285(CHEMBL3334980)
Affinity DataIC50:  1.78E+3nMAssay Description:Inhibition of DRAK2 (unknown origin) using 33P-ATP after 30 mins by Trilux scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  2.11E+3nMAssay Description:Inhibition of DRAK1 (unknown origin) using 100 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  2.22E+3nMAssay Description:Inhibition of DRAK2 (unknown origin) using 500 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  2.25E+3nMAssay Description:Inhibition of DRAK1 (unknown origin) using 33P-ATP after 30 mins by Trilux scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  2.85E+3nMAssay Description:Inhibition of DRAK1 (unknown origin) using 250 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024285(CHEMBL3334980)
Affinity DataIC50:  4.94E+3nMAssay Description:Inhibition of DRAK1 (unknown origin) using 33P-ATP after 30 mins by Trilux scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataIC50:  5.91E+3nMAssay Description:Inhibition of DRAK1 (unknown origin) using 500 uM ATP by biochemical assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024285(CHEMBL3334980)
Affinity DataKd:  13nMAssay Description:Binding affinity to DRAK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataKd:  4.90nMAssay Description:Binding affinity to DRAK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024296(CHEMBL3334988)
Affinity DataKd:  180nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024295(CHEMBL3334983)
Affinity DataKd:  960nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024287(CHEMBL3334982)
Affinity DataKd:  2.70E+3nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024286(CHEMBL3334981)
Affinity DataKd:  33nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024285(CHEMBL3334980)
Affinity DataKd:  27nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataKd:  9nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024283(CHEMBL3334978)
Affinity DataKd:  510nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024282(CHEMBL3334970)
Affinity DataKd:  7.20E+3nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024281(CHEMBL3334959)
Affinity DataKd:  1.60E+3nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024280(CHEMBL3334958)
Affinity DataKd:  1.90E+3nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024279(CHEMBL3334955)
Affinity DataKd:  1.60E+3nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024278(CHEMBL3334949)
Affinity DataKd:  3.20E+3nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024272(CHEMBL3334948)
Affinity DataKd:  2.30E+3nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024271(CHEMBL3334946)
Affinity DataKd:  660nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024269(CHEMBL3334945)
Affinity DataKd:  2.00E+3nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024268(CHEMBL3334961)
Affinity DataKd:  1.60E+3nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024263(CHEMBL3334963)
Affinity DataKd:  530nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase 17B(Homo sapiens (Human))
Ku Leuven

Curated by ChEMBL
LigandPNGBDBM50024267(CHEMBL3334962)
Affinity DataKd:  2.20E+3nMAssay Description:Binding affinity to DRAK2 (unknown origin) ATP siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed